title: Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival.
abstract: Galectin-3 plays an important role in fibroblast activation and fibrosis in animal models. Increased galectin-3 levels are associated with poor long-term survival in heart failure (HF). We examined the relation between plasma galectin-3 levels and myocardial indexes of systolic HF. We measured plasma galectin-3 in 133 subjects with chronic HF and 45 with advanced decompensated HF using echocardiographic and hemodynamic evaluations. In the chronic HF cohort, median plasma galectin-3 level was 13.9 ng/ml (interquartile range 12.1 to 16.9). Higher galectin-3 was associated with more advanced age (r = 0.22, p = 0.010), poor renal function (estimated glomerular filtration rate, r = -0.24, p = 0.007; cystatin C, r = 0.38, p <0.0001) and predicted all-cause mortality (hazard ratio 1.86, 95% confidence interval 1.36 to 2.54, p <0.001). In multivariate analysis, galectin-3 remained an independent predictor of all-cause mortality after adjusting for age, estimated glomerular filtration rate, left ventricular (LV) ejection fraction, and mitral early diastolic myocardial relaxation velocity at septal mitral annulus (hazard ratio 1.94, 95% confidence interval 1.30 to 2.91, p = 0.001). However, galectin-3 did not predict the combined end point of all-cause mortality, cardiac transplantation, or HF hospitalization (p >0.05). Furthermore, there were no relations between galectin-3 and LV end-diastolic volume index (r = -0.05, p = 0.61), LV ejection fraction (r = 0.10, p = 0.25), or LV diastolic function (mitral early diastolic myocardial relaxation velocity at septal mitral annulus, r = 0.06, p = 0.52; left atrial volume index, r = 0.08, p = 0.41). In the advanced decompensated HF cohort, we did not observe any relation between galectin-3 and echocardiographic or hemodynamic indexes. In conclusion, high plasma galectin-3 levels were associated with renal insufficiency and poorer survival in patients with chronic systolic HF. However, we did not observe a relation between galectin-3 and echocardiographic or hemodynamic indexes.
authors: Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Ohio, USA. tangw@ccf.org
authors: W H Wilson
authors: WH
authors: Tang
authors: Kevin
authors: K
authors: Shrestha
authors: Zhili
authors: Z
authors: Shao
authors: Allen G
authors: AG
authors: Borowski
authors: Richard W
authors: RW
authors: Troughton
authors: James D
authors: JD
authors: Thomas
authors: Allan L
authors: AL
authors: Klein
references: Hypertension. 2006 Nov;48(5):830-1
references: 16982959
references: J Card Fail. 2006 Oct;12(8):601-7
references: 17045178
references: Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1226-32
references: 18178715
references: Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H404-12
references: 19098114
references: Clin Res Cardiol. 2010 May;99(5):323-8
references: 20130888
references: J Am Coll Cardiol. 2006 Sep 19;48(6):1217-24
references: 16979009
references: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5060-5
references: 16549783
references: Circ Heart Fail. 2009 Mar;2(2):98-104
references: 19808324
references: J Card Fail. 2008 Jun;14(5):394-9
references: 18514931
references: Ann Med. 2011 Feb;43(1):60-8
references: 21189092
references: Eur J Heart Fail. 2010 Feb;12(2):193-6
references: 20042425
references: Hypertension. 2006 Nov;48(5):979-87
references: 16982960
references: J Pathol. 1999 Mar;187(4):481-9
references: 10398110
references: Ann Intern Med. 1999 Mar 16;130(6):461-70
references: 10075613
references: Biochem Pharmacol. 2008 May 1;75(9):1797-806
references: 18342293
references: Circulation. 2004 Nov 9;110(19):3121-8
references: 15520318
references: J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
references: 16376782
references: Am J Cardiol. 2005 Jul 15;96(2):257-62
references: 16018853
references: Eur J Heart Fail. 2010 Aug;12(8):826-32
references: 20525986
references: Am J Pathol. 2008 Feb;172(2):288-98
references: 18202187
references: Clin Chim Acta. 2009 Nov;409(1-2):96-9
references: 19747906
references: J Am Coll Cardiol. 2004 Feb 4;43(3):416-22
references: 15013124